• Advances in Cell-Based Immunotherapies: CAR-T Cell Therapy vs TCR Therapy

  • Jul 25 2024
  • Duración: 28 m
  • Podcast

Advances in Cell-Based Immunotherapies: CAR-T Cell Therapy vs TCR Therapy  Por  arte de portada

Advances in Cell-Based Immunotherapies: CAR-T Cell Therapy vs TCR Therapy

  • Resumen

  • In this episode of Conversations in Drug Development, host Harriet Edwards is joined by two regulatory experts from Boyds, Dr Patrick Ginty and Monica Pianella, to discuss cell-based immunotherapies, focusing on CAR-T cells and TCR-T cells.

    Patrick and Monica delve into these cutting-edge treatments, discussing their uses, the complexities of their production, and important safety considerations. They also highlight recent advancements and the exciting future prospects for these therapies in cancer treatment and other areas.

    Tune in for an insightful discussion on the future of cell-based immunotherapies, examining both the hurdles and the potential of these innovative treatments.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Advances in Cell-Based Immunotherapies: CAR-T Cell Therapy vs TCR Therapy

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.